BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32518084)

  • 1. Stress-induced Norepinephrine Downregulates CCL2 in Macrophages to Suppress Tumor Growth in a Model of Malignant Melanoma.
    Steinberger KJ; Bailey MT; Gross AC; Sumner LA; Voorhees JL; Crouser N; Curry JM; Wang Y; DeVries AC; Marsh CB; Glaser R; Yang EV; Eubank TD
    Cancer Prev Res (Phila); 2020 Sep; 13(9):747-760. PubMed ID: 32518084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor immune response varies among individuals: A gene expression profiling of mouse melanoma.
    Yang X; Ma Z; Zhang Y; Wu J; Huang J; Zhao W; Mo F; Lin Z; Xu Y; Zhou Z; Chen S
    Int Immunopharmacol; 2020 Mar; 80():106211. PubMed ID: 31972424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.
    Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Hidaka T; Aiba S
    Anticancer Res; 2017 Jul; 37(7):3461-3471. PubMed ID: 28668835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STC1 competitively binding βPIX enhances melanoma progression via YAP nuclear translocation and M2 macrophage recruitment through the YAP/CCL2/VEGFA/AKT feedback loop.
    Ren Z; Xu Z; Chang X; Liu J; Xiao W
    Pharmacol Res; 2024 Jun; 204():107218. PubMed ID: 38768671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.
    Wehbe M; Soudja SM; Mas A; Chasson L; Guinamard R; de Tenbossche CP; Verdeil G; Van den Eynde B; Schmitt-Verhulst AM
    PLoS One; 2012; 7(11):e49419. PubMed ID: 23173060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
    Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
    J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles.
    Urbanska AM; Khanin R; Alidori S; Wong S; Mello BP; Almeida BA; Chen F; Ma K; Turker MZ; Korontsvit T; Scheinberg DA; Zanzonico PB; Wiesner U; Bradbury MS; Quinn TP; McDevitt MR
    Cancer Biother Radiopharm; 2020 Aug; 35(6):459-473. PubMed ID: 32013538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
    Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
    Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression.
    Calvani M; Pelon F; Comito G; Taddei ML; Moretti S; Innocenti S; Nassini R; Gerlini G; Borgognoni L; Bambi F; Giannoni E; Filippi L; Chiarugi P
    Oncotarget; 2015 Mar; 6(7):4615-32. PubMed ID: 25474135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth.
    Armaiz-Pena GN; Gonzalez-Villasana V; Nagaraja AS; Rodriguez-Aguayo C; Sadaoui NC; Stone RL; Matsuo K; Dalton HJ; Previs RA; Jennings NB; Dorniak P; Hansen JM; Arevalo JM; Cole SW; Lutgendorf SK; Sood AK; Lopez-Berestein G
    Oncotarget; 2015 Feb; 6(6):4266-73. PubMed ID: 25738355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Foxp3+ macrophages in both untreated and B16 melanoma-bearing mice.
    Mayer CT; Kühl AA; Loddenkemper C; Sparwasser T
    Blood; 2012 Feb; 119(5):1314-5. PubMed ID: 22308282
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis.
    Wang X; He X; Zhao F; Wang J; Zhang H; Shi F; Zhang Y; Cai K; Dou J
    J Transl Med; 2014 Mar; 12():68. PubMed ID: 24625224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: roles of adipocytes and M2-macrophages.
    Jung JI; Cho HJ; Jung YJ; Kwon SH; Her S; Choi SS; Shin SH; Lee KW; Park JH
    Int J Cancer; 2015 Jan; 136(2):258-70. PubMed ID: 24844408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through β-adrenergic-activated CXCL5-CXCR2-Erk signaling cascades.
    Cao M; Huang W; Chen Y; Li G; Liu N; Wu Y; Wang G; Li Q; Kong D; Xue T; Yang N; Liu Y
    Int J Cancer; 2021 Jul; 149(2):460-472. PubMed ID: 33751565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived CCL20 affects B16 melanoma growth in mice.
    Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
    J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment.
    Liu W; Stachura P; Xu HC; Váraljai R; Shinde P; Ganesh NU; Mack M; Van Lierop A; Huang A; Sundaram B; Lang KS; Picard D; Fischer U; Remke M; Homey B; Roesch A; Häussinger D; Lang PA; Borkhardt A; Pandyra AA
    Cancer Res; 2022 Jan; 82(2):264-277. PubMed ID: 34810198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
    Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
    Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.
    Li N; Qin J; Lan L; Zhang H; Liu F; Wu Z; Ni H; Wang Y
    Cancer Biol Ther; 2015; 16(2):297-306. PubMed ID: 25756512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.